EFFECT OF A DELAY IN STARTING CHEMOTHERAPY FOR PATIENTS (PTS) WITH DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA (NHL)

被引：0
|
作者：
BIERMAN, P [1 ]
ANDERSON, J [1 ]
VOSE, J [1 ]
SLOWIACZEK, K [1 ]
MORRIS, M [1 ]
ARMITAGE, J [1 ]
机构：
[1] UNIV NEBRASKA,MED CTR,OMAHA,NE 68105
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A165 / A165
页数：1
相关论文
共 50 条
  • [41] IMMUNOLOGICAL PHENOTYPE IN 30 PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA
    WARNKE, R
    MILLER, R
    GROGAN, T
    PEDERSON, M
    DILLEY, J
    LEVY, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (06): : 293 - 300
  • [42] COMBINATION CHEMOTHERAPY SPECIFICALLY DEVISED FOR ELDERLY PATIENTS WITH UNFAVORABLE NON-HODGKINS-LYMPHOMA
    ZAGONEL, V
    TIRELLI, U
    CARBONE, A
    ERRANTE, D
    MORASSOT, S
    SORIO, R
    MONFARDINI, S
    CANCER INVESTIGATION, 1990, 8 (06) : 577 - 582
  • [43] EFFECT OF AGE ON CAUSE OF DEATH IN PATIENTS TREATED WITH CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS LYMPHOMA (NHL)
    VOSE, JM
    ARMITAGE, JO
    WEISENBURGER, DD
    BIERMAN, PJ
    MORAVEC, D
    HUTCHINS, M
    HOWE, D
    SORENSEN, S
    DOWLING, M
    OKERBLOOM, J
    PEVNICK, W
    PACKARD, W
    THOMPSON, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 211 - 211
  • [44] EPSTEIN-BARR-VIRUS AND PROGRESSION OF NON-HODGKINS-LYMPHOMA TO KI-1-POSITIVE, ANAPLASTIC LARGE-CELL PHENOTYPE
    DIGIUSEPPE, JA
    WU, TC
    ZEHNBAUER, BA
    MCDOWELL, PR
    BARLETTA, JM
    AMBINDER, RF
    MANN, RB
    MODERN PATHOLOGY, 1995, 8 (05) : 553 - 559
  • [45] COPBLAM-III - INFUSIONAL COMBINATION CHEMOTHERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA
    BOYD, DB
    COLEMAN, M
    PAPISH, SW
    TOPILOW, A
    KOPEL, SK
    BERNHARDT, B
    FILES, JC
    SCHWARTZ, S
    GAYNOR, M
    MCDERMOTT, D
    REISMAN, AM
    COLEMAN, BL
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 425 - 433
  • [46] CHEMOTHERAPY FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA WITH NON-CROSS-RESISTANT ALTERNATING AVCP/EMLP REGIMENS
    YAMAZAKI, H
    OGAWA, M
    HORIKOSHI, N
    INAGAKI, J
    INOUE, K
    NAKAMURA, T
    UENO, K
    ITO, Y
    IMAJO, K
    MUKAIYAMA, T
    MIYAOKA, K
    NAKATA, H
    ACTA HAEMATOLOGICA JAPONICA, 1986, 49 (07): : 1404 - 1411
  • [47] EFFECT OF CHEMOTHERAPY ON RESTING ENERGY-EXPENDITURE IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - RESULTS OF A SEQUENTIAL STUDY
    DELARUE, J
    LEREBOURS, E
    TILLY, H
    RIMBERT, A
    HOCHAIN, P
    GUEDON, C
    PIGUET, H
    COLIN, R
    CANCER, 1990, 65 (11) : 2455 - 2459
  • [48] DIFFUSE LARGE CELL NON-HODGKINS LYMPHOMA - RESULTS OF M-BACOD COMBINATION CHEMOTHERAPY
    POLLIACK, A
    UZIELY, B
    ISACSON, R
    LUGASSY, G
    ROCHLEMER, S
    GEZ, E
    LIBSON, E
    SULKES, A
    WESHLER, Z
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1988, 24 (9-10): : 619 - 622
  • [49] NON-HODGKINS LYMPHOMA (NHL) - EFFECT OF HISTOLOGIC SUBTYPE ON TOXICITY AND RESPONSE TO CHEMOTHERAPY
    OKEN, MM
    COSTELLO, WG
    JOHNSON, GJ
    LENHARD, RE
    EZDINLI, E
    GLICK, JH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 376 - 376
  • [50] THE RESPONSE OF DIFFUSE LARGE-CELL AND OTHER INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMAS TO ADRIAMYCIN CONTAINING COMBINATION CHEMOTHERAPY
    LISHNER, M
    SLINGERLAND, J
    THERESA, C
    SUTCLIFFE, SB
    LEUKEMIA & LYMPHOMA, 1994, 13 (1-2) : 131 - 136
12345